Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retina Vascular Pathology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01580020
What this trial is testing

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Who this might be right for
Retinal Vein Occlusion
Novartis Pharmaceuticals 175
Large-scale testing (Phase 3)Study completedNCT01377597
What this trial is testing

Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Novartis Pharmaceuticals 47
Testing effectiveness (Phase 2)Ended earlyNCT02681809
What this trial is testing

Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR

Who this might be right for
Diabetic RetinopathyPosterior Vitreous DetachmentDisease Progression
ThromboGenics 48
Not applicableNot Yet RecruitingNCT07497815
What this trial is testing

Artificial Intelligence-assisted Diagnosis in Ophthalmology

Who this might be right for
Macular DegenerationDiabetic Retinopathy (DR)Glaucoma+2 more
Marisse Masis-Solano 15,000
Testing effectiveness (Phase 2)Study completedNCT00510965
What this trial is testing

Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)

Who this might be right for
Choroidal Neovascularization
University Hospital, Bonn 10
Testing effectiveness (Phase 2)Study completedNCT03902925
What this trial is testing

Pain During Pars Plana Vitrectomy With Sub-tenon Anesthesia

Who this might be right for
Retinal DiseaseDiabetic RetinopathyMaculopathy
University of Sao Paulo 56
Not applicableUnknownNCT04101604
What this trial is testing

Biomarkers of Common Eye Diseases

Who this might be right for
UveitisDiabetic RetinopathyAge-related Macular Degeneration+3 more
Sun Yat-sen University 220
Not applicableStudy completedNCT06559488
What this trial is testing

IVB for Post-vitrectomy Hemorrhage in Diabetic Eyes

Who this might be right for
Diabetic RetinopathyVitreous Hemorrhage
Universitas Padjadjaran 18
Large-scale testing (Phase 3)Study completedNCT01599650
What this trial is testing

Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Novartis Pharmaceuticals 455
Not applicableLooking for participantsNCT07420374
What this trial is testing

Ambulatory Stroke Unit Treatment for Elderly Patients

Who this might be right for
Ischemic StrokeTransient Ischemic Attack (TIA)Retinal Ischemia
University Hospital Heidelberg 400
Not applicableWithdrawnNCT06398080
What this trial is testing

An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Wet Age-related Macular Degeneration (AMD)Diabetic Macular Edema (DME)+1 more
Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00690768
What this trial is testing

Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA)

Who this might be right for
Diabetic RetinopathyRetinal Detachment
University of Sao Paulo 20
Early research (Phase 1)Study completedNCT00071227
What this trial is testing

Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders

Who this might be right for
Macular DegenerationRetinal Vein Occlusion
National Eye Institute (NEI) 16
Not applicableLooking for participantsNCT07245082
What this trial is testing

Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
National Taiwan University Hospital 2,000
Post-approval studies (Phase 4)UnknownNCT04215445
What this trial is testing

Effect of SGLT2 Inhibition on OCT-A Parameters in Diabetic CKD

Who this might be right for
Diabetic RetinopathyChronic Kidney DiseasesDiabetes Mellitus
National University of Malaysia 90
Not applicableStudy completedNCT07495670
What this trial is testing

Comparison of 4 Methods of Eye Drops for Pupil Dilation in Diabetic Patients

Who this might be right for
Diabetes (DM)Retinopathy, DiabeticPupil Dilation
Burapha University 84
Not applicableStudy completedNCT01363570
What this trial is testing

Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes

Who this might be right for
Age Related Macular Degeneration
McMaster University 70
Not applicableUnknownNCT04488887
What this trial is testing

OCTA Metrics Repeatability and Reproducibility in Different Disorders

Who this might be right for
Diabetic RetinopathyMyopiaChoroidal Neovascularization+1 more
Tanta University 80
Testing effectiveness (Phase 2)Study completedNCT02537054
What this trial is testing

Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)

Who this might be right for
Pseudoxanthoma Elasticum
University Hospital, Bonn 15
Testing effectiveness (Phase 2)Study completedNCT06011798
What this trial is testing

Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)

Who this might be right for
Diabetic Macular EdemaRetinal DiseaseMacular Edema+6 more
Unity Biotechnology, Inc. 52
Next Page